Close Menu

NEW YORK – Cardea Bio and Nanosens Innovations said today that they are launching an early-access program for the Genome Sensor, a biosensor device based on their CRISPR-Chip graphene transistor technology.

The companies are starting the early-access program ahead of schedule in conjunction with their planned merger, which they also announced today, and will sell CRISPR-Chip technology-based products under the Nanosens brand.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.